Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document
Miravitlles Fernández, Marc
Soriano, Joan Bautista
MetadataShow full item record
Abstract Chronic obstructive pulmonary disease (COPD) is one of the most prevalent diseases in the World, and one of the most important causes of mortality and morbidity. In adults 40 years and older, it affects more than 10% of the population and has enormous personal, family and social burden. Tobacco smoking is its main cause, but not the only one, and there is probably a genetic predisposition that increases the risk in some patients. The paradigm of this disease is changing in Spain, with an increase of women that has occurred in recent years. Many of the physio pathological mechanisms of this condition are well known, but the psychological alterations to which it leads, the impact of COPD on relatives and caregivers, the limitation of daily life observed in these patients, and the economic and societal burden that they represent for the health system, are not so well-known. A major problem is the high under-diagnosis, mainly due to difficulties for obtaining, in a systematic way, spirometries in hospitals and health-care centers. For this reason, the Fundación de Ciencias de la Salud and the Spanish National Network Center for Research in Respiratory Diseases (CIBERES) have brought together experts in COPD, patients and their organizations, clinical psychologists, experts in health economics, nurses and journalists to obtain their opinion about COPD in Spain. They also discussed the scientific bibliometrics on COPD that is being carried out from the CIBERES and speculated on the future of this condition. The format of the meeting consisted in the discussion of a series of questions that were addressed by different speakers and discussed until a consensus conclusion was reached. Keywords: Chronic Obstructive Pulmonary Disease; Health Economics; Health-Care burden; Patients organizations; Psychological impact; Research bibliometrics; Spirometry.
Is part ofRevista Espanola de Quimioterapia, 2020, vol. 33, num. 1, p. 49-67
European research projects
Except where otherwise noted, this item's license is described as cc-by-nc (c) Emilio Bouza et al., 2020
Showing items related by title, author, creator and subject.
Treatment strategies after acute exacerbations of chronic obstructive pulmonary disease: Impact on mortality Casas-Méndez, Luis Fernando; Abadías, María José; Yuguero Torres, Oriol; Bardés Robles, Ignasi; Barbé Illa, Ferran; Batlle Garcia, Jordi de (Public Library of Science, 2018)Introduction Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common reason for presentation to emergency departments (ED), but the management of these episodes is often heterogeneous regardless ...
The Bronchodilator Test with Increasing Doses of Terbutaline in Chronic Obstructive Pulmonary Disease Patients Rodríguez-Carballeira, M.; Heredia, J. L.; Rué i Monné, Montserrat; Quintana, Salvador; Gómez, S. (Elsevier, 2001)There is no uniform consensus on the dose of bronchodilator to be used in the bronchodilator test (BDT). The objective of the study was to determine the dose of inhaled terbutaline that can safely achieve a greater number ...
Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study Montserrat i Capdevila, Josep; Godoy i García, Pere; Marsal Mora, Josep Ramon; Barbé Illa, Ferran; Galván, Leonardo (BioMed Central, 2015)Background: The risk of exacerbation in chronic obstructive pulmonary disease (COPD) depends on the severity of disease and other less well known factors. Predictive models of exacerbation are more accurate than the forced ...